Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Krnjevic K. (1993). Central cholinergic mechanisms and function, Prog. Brain Res,
98: 285–92.
Krnjevic´ K. (2008). Electrophysiology of cerebral ischemia. Neuropharmacology, 55:
319–33.
Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson
CN, Goddard A, Mason GF. (2002). Glutamate and GABA systems as targets for
novel antidepressant and mood–stabilizing treatments. Molecular Psychiatry, 7:
71–80.
Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K. (2007). Effect of curcumin on
inflammation and oxidative stress in cisplatin–induced experimental
nephrotoxicity. J Agric Food Chem, 55: 10150–10155.
Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA,
Kilbourn MR. (1999). In vivo mapping of cerebral acetylcholinesterase activity in
aging and Alzheimer’s disease. Neurology, 52: 691–699.
Kulkarni RN. (2002). Receptors for insulin and insulin–like growth factor–1 and
insulin receptor substrate–1 mediate pathways that regulate islet function.
Biochem Soc Trans, 30: 317–322.
Kumagai AK. (1995). Upregulation of blood brain barrier Glut–1 glucose transporter
protein and mRNA in experimental chronic hypoglycemia. Diabetes, 44: 1399–
1404.